Jeroen B. Van Beek's most recent trade in Kalaris Therapeutics Inc. was a trade of 16,074 Common Stock done at an average price of $7.5 . Disclosure was reported to the exchange on Nov. 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 16 Nov 2022 | 16,074 | 333,726 | - | 7.5 | 120,528 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.20 per share. | 11 Nov 2022 | 36,592 | 349,800 | - | 8.2 | 299,904 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 08 Nov 2022 | 13,109 | 386,392 | - | 8.0 | 104,901 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 08 Nov 2022 | 299 | 399,501 | - | 8 | 2,392 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.36 per share. | 20 Oct 2022 | 1,070 | 399,800 | - | 9.4 | 10,016 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.89 per share. | 02 Sep 2022 | 493 | 400,870 | - | 7.9 | 3,889 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.30 per share. | 16 Aug 2022 | 15,590 | 386,363 | - | 8.3 | 129,473 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 15,000 | 401,363 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 20 Jul 2022 | 1,058 | 401,953 | - | 5.2 | 5,517 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 14,000 | 403,011 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.63 per share. | 03 Jun 2022 | 515 | 389,011 | - | 3.6 | 1,871 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 4.40 per share. | 17 May 2022 | 15,262 | 389,526 | - | 4.4 | 67,167 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.68 per share. | 20 Apr 2022 | 852 | 404,788 | - | 6.7 | 5,695 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 02 Mar 2022 | 516 | 382,384 | - | 9.0 | 4,651 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.32 per share. | 16 Feb 2022 | 15,322 | 382,900 | - | 8.3 | 127,525 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.75 per share. | 20 Jan 2022 | 4,656 | 398,222 | - | 8.8 | 40,752 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 56,744 | 56,744 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 23,256 | 405,640 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.13 per share. | 16 Nov 2021 | 15,203 | 403,392 | - | 21.1 | 321,262 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.17 per share. | 29 Sep 2021 | 12,171 | 422,008 | - | 25.2 | 306,294 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 29 Sep 2021 | 3,413 | 418,595 | - | 25.1 | 85,575 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 29 Sep 2021 | 1,000 | 434,179 | - | 25.0 | 25,037 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 38.62 per share. | 01 Mar 2021 | 4,332 | 489,830 | - | 38.6 | 167,301 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.21 per share. | 01 Mar 2021 | 1,600 | 488,230 | - | 39.2 | 62,733 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.71 per share. | 19 Feb 2021 | 4,165 | 499,080 | - | 41.7 | 173,720 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 19 Feb 2021 | 2,200 | 496,280 | - | 42.8 | 94,201 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.18 per share. | 19 Feb 2021 | 1,418 | 494,862 | - | 39.2 | 55,556 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.32 per share. | 19 Feb 2021 | 700 | 494,162 | - | 40.3 | 28,227 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.53 per share. | 19 Feb 2021 | 600 | 498,480 | - | 41.5 | 24,917 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.44 per share. | 18 Feb 2021 | 800 | 503,995 | - | 40.4 | 32,349 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.50 per share. | 18 Feb 2021 | 750 | 503,245 | - | 41.5 | 31,126 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.84 per share. | 18 Feb 2021 | 535 | 504,795 | - | 39.8 | 21,312 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.82 per share. | 17 Feb 2021 | 15,205 | 441,608 | - | 17.8 | 270,953 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 22.80 per share. | 17 Feb 2021 | 15,201 | 457,321 | - | 22.8 | 346,583 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.65 per share. | 17 Feb 2021 | 15,196 | 490,134 | - | 39.6 | 602,521 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.08 per share. | 17 Feb 2021 | 5,916 | 435,179 | - | 25.1 | 148,362 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.86 per share. | 17 Feb 2021 | 513 | 441,095 | - | 19.9 | 10,188 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 37.93 per share. | 17 Feb 2021 | 512 | 472,522 | - | 37.9 | 19,420 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 22.87 per share. | 17 Feb 2021 | 508 | 456,813 | - | 22.9 | 11,618 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.76 per share. | 16 Feb 2021 | 2,700 | 508,030 | - | 41.8 | 112,761 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.22 per share. | 16 Feb 2021 | 1,300 | 505,430 | - | 41.2 | 53,582 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 38.42 per share. | 16 Feb 2021 | 500 | 507,130 | - | 38.4 | 19,212 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.72 per share. | 16 Feb 2021 | 400 | 506,730 | - | 39.7 | 15,887 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.52 per share. | 16 Feb 2021 | 400 | 507,630 | - | 42.5 | 17,009 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 16 Feb 2021 | 100 | 505,330 | - | 41.6 | 4,156 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.19 per share. | 02 Feb 2021 | 48,910 | 510,730 | - | 41.2 | 2,014,603 | Common Stock |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Jeroen B. Van Beek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 35,000 | 559,640 | - | 0 | Common Stock |